Aviance Capital Partners’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
85,786
+1,949
+2% +$36.6K 0.17% 115
2025
Q4
$1.6M Buy
83,837
+2,138
+3% +$39.2K 0.18% 110
2025
Q3
$1.41M Buy
81,699
+793
+1% +$13.5K 0.17% 119
2025
Q2
$1.49M Sell
80,906
-2,070
-2% -$38.5K 0.19% 117
2025
Q1
$1.71M Buy
82,976
+1,447
+2% +$29.6K 0.24% 94
2024
Q4
$1.54M Sell
81,529
-606
-0.7% -$12.5K 0.21% 108
2024
Q3
$1.81M Buy
82,135
+713
+0.9% +$15.2K 0.24% 101
2024
Q2
$1.66M Buy
81,422
+2,623
+3% +$52.2K 0.24% 102
2024
Q1
$1.58M Buy
78,799
+2,465
+3% +$47.4K 0.24% 105
2023
Q4
$1.38M Sell
76,334
-14,362
-16% -$243K 0.3% 84
2023
Q3
$1.54M Sell
90,696
-12,500
-12% -$232K 0.35% 72
2023
Q2
$1.97M Buy
103,196
+1,905
+2% +$35.9K 0.42% 58
2023
Q1
$1.9M Buy
101,291
+2,336
+2% +$44.7K 0.42% 58
2022
Q4
$1.96M Sell
98,955
-15,707
-14% -$310K 0.46% 50
2022
Q3
$2.08M Buy
114,662
+4,987
+5% +$99.9K 0.52% 47
2022
Q2
$2.19M Buy
109,675
+13,982
+15% +$293K 0.49% 53
2022
Q1
$2.13M Buy
95,693
+17,917
+23% +$401K 0.39% 68
2021
Q4
$1.99M Buy
77,776
+2,295
+3% +$55.1K 0.33% 67
2021
Q3
$1.71M Sell
75,481
-3,038
-4% -$73.2K 0.3% 88
2021
Q2
$1.81M Buy
78,519
+8,245
+12% +$189K 0.32% 79
2021
Q1
$1.53M Sell
70,274
-5,039
-7% -$106K 0.29% 89
2020
Q4
$1.53M Buy
75,313
+2,838
+4% +$54.2K 0.31% 79
2020
Q3
$1.31M Sell
72,475
-1,659
-2% -$30.2K 0.3% 82
2020
Q2
$1.32M Sell
74,134
-1,166
-2% -$20.6K 0.33% 76
2020
Q1
$1.16M Sell
75,300
-1,433
-2% -$25.2K 0.36% 70
2019
Q4
$1.46M Buy
76,733
+2,261
+3% +$40.9K 0.37% 78
2019
Q3
$1.3M Buy
74,472
+4,704
+7% +$82.4K 0.38% 83
2019
Q2
$1.24M Sell
69,768
-1,811
-3% -$31.1K 0.34% 90
2019
Q1
$1.26M Sell
71,579
-892
-1% -$15.6K 0.36% 79
2018
Q4
$1.22M Sell
72,471
-794
-1% -$14.1K 0.43% 65
2018
Q3
$1.37M Buy
73,265
+5,317
+8% +$96.4K 0.33% 73
2018
Q2
$1.16M Buy
67,948
+11,693
+21% +$196K 0.33% 76
2018
Q1
$927K Buy
56,255
+4,357
+8% +$76.1K 0.28% 102
2017
Q4
$909K Sell
51,898
-2,195
-4% -$39K 0.3% 97
2017
Q3
$1M Sell
54,093
-2,907
-5% -$53.3K 0.34% 82
2017
Q2
$1.04M Buy
57,000
+9,864
+21% +$173K 0.34% 86
2017
Q1
$820K Sell
47,136
-4,684
-9% -$79.9K 0.3% 104
2016
Q4
$804K Buy
51,820
+6,728
+15% +$109K 0.28% 104
2016
Q3
$788K Sell
45,092
-2,082
-4% -$36.2K 0.28% 98
2016
Q2
$785K Sell
47,174
-652
-1% -$10.6K 0.29% 97
2016
Q1
$761K Sell
47,826
-4,260
-8% -$65.8K 0.26% 101
2015
Q4
$906K Buy
52,086
+7,572
+17% +$130K 0.31% 92
2015
Q3
$726K Buy
44,514
+5,730
+15% +$110K 0.3% 103
2015
Q2
$769K Buy
38,784
+5,331
+16% +$109K 0.29% 109
2015
Q1
$688K Buy
33,453
+19,803
+145% +$400K 0.25% 122
2014
Q4
$274K Sell
13,650
-5,550
-29% -$108K 0.1% 198
2014
Q3
$362K Buy
+19,200
New +$383K 0.14% 182

Other funds holding THQ

Aviance Capital Partners's THQ Position: Q1 2026 in Review

Aviance Capital Partners increased its abrdn Healthcare Opportunities Fund (THQ) stake by 2.3% in Q1 2026, buying an estimated $36.6K and bringing the position to 85,786 shares worth $1.44M. The position accounts for 0.17% of the portfolio, ranked #115.

Aviance Capital Partners first reported a position in THQ in Q3 2014 and has held it in 47 quarters since. The position peaked at $2.19M in Q2 2022. 88 funds tracked by Wall St. Rank hold THQ as of Q1 2026.

  • Aviance Capital Partners held 85,786 shares of abrdn Healthcare Opportunities Fund worth $1.44M as of Q1 2026.
  • Aviance Capital Partners bought 1,949 abrdn Healthcare Opportunities Fund shares in Q1 2026, an estimated $36.6K.
  • abrdn Healthcare Opportunities Fund made up 0.17% of Aviance Capital Partners's portfolio in Q1 2026, its #115 holding.
  • Aviance Capital Partners first reported a position in abrdn Healthcare Opportunities Fund in Q3 2014 and has held it in 47 quarters since.
  • Aviance Capital Partners's abrdn Healthcare Opportunities Fund position peaked at $2.19M in Q2 2022.
  • 88 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.